Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
This is a combination herbal preparation containing extracts from three plants: Eleutherococcus (commonly known as Siberian ginseng), Achillea millefolium (yarrow), and Lamium album (white dead nettle). The combination has been studied for its potential effects in treating atopic dermatitis, but clinical trials have shown no significant benefit over placebo. Each component herb is traditionally used in herbal medicine for various purposes—Eleutherococcus as an adaptogen, Achillea millefolium for wound healing and anti-inflammatory effects, and Lamium album for reducing swelling and breaking up mucus. However, there is insufficient scientific evidence to support the efficacy of this specific tri-herbal combination or its individual components for most medical indications[1][2][3][4][5][6].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on eleutherococcus + achillea millefolium + lamium album.